The EpCAM+, CD24−, CD44+, and ALDH+ populations across different subtypes of breast cancers represent anatomically distinct BCSCs with respective EMT (epithelial-to-mesenchymal transition) and MET (mesenchymal-to-epithelial transition) gene expression profiles. Here, EPCAM is linked to breast carcinoma.